Ticker brief
ARCT
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
22
authors 14d
12
crowd 14d
+0.5σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-25 · now +0.40 (−1 bearish … +1 bullish)
Who spoke12
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Brad_E_Schulz | C | · | 5 | +0.45 |
| @fundmyfund | B | -1.58 | 4 | +0.30 |
| @Markadiusz45 | C | +1.18 | 2 | +0.20 |
| @Pharmdca | C | +0.82 | 2 | +0.20 |
| @MrStockLockPro1 | C | -0.94 | 2 | +0.42 |
| @BiopharmIQ | B | · | 1 | +0.00 |
| @OTR444 | C | -1.39 | 1 | +0.20 |
| @Analytica_X | B | +1.03 | 1 | +0.30 |
| @TrendSpider | C | -1.01 | 1 | +0.30 |
| @OptionsFlowBoss | C | · | 1 | +0.20 |
| @BPharmCatalyst | C | · | 1 | -0.40 |
| @WallStDiaries | C | -0.20 | 1 | +0.45 |
Recent signals22of 22 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-25 | @Brad_E_Schulz | +0.15 | Lists stocks up at least 4% on 1.5x or greater average volume. | · | tweet ↗ |
| 2026-08-25 | @fundmyfund | +0.65 | Says ARCT's exceptional strength is continuing. | · | tweet ↗ |
| 2026-08-24 | @fundmyfund | +0.45 | Observes ARCT strength and attributes it tentatively to unspecified MRNA news. | · | tweet ↗ |
| 2026-08-24 | @Brad_E_Schulz | +0.30 | Lists stocks up at least 4% with elevated volume multiples. | · | tweet ↗ |
| 2026-08-22 | @WallStDiaries | +0.45 | Arcturus rose more than 60% for the week amid improving biotech sentiment. | · | tweet ↗ |
| 2026-08-21 | @Brad_E_Schulz | +0.40 | Reports positive sector performance and names leading stocks gaining at least 5%. | · | tweet ↗ |
| 2026-08-21 | @Brad_E_Schulz | +0.70 | Lists leading stocks up at least 4% on at least 1.5 times average daily volume. | · | tweet ↗ |
| 2026-08-21 | @BPharmCatalyst | -0.40 | ARCT reported a wider Q2 loss and lower collaboration revenue, partly offset by cash runway and catalysts. | · | tweet ↗ |
| 2026-08-21 | @fundmyfund | -0.35 | Calls ARCT's pre-news weekly chart incredibly poor and attributes the move to luck. | · | tweet ↗ |
| 2026-08-21 | @fundmyfund | +0.45 | Quantifies ARCT and MRNA gains following positive late-stage cancer-vaccine results. | · | tweet ↗ |
| 2026-08-21 | @OptionsFlowBoss | +0.20 | Lists unusually high bullish options-volume multiples; later bearish remark is not assigned to named stocks. | · | tweet ↗ |
| 2026-08-21 | @Brad_E_Schulz | +0.70 | Lists intraday leaders up at least 4% on at least 1.5 times average volume. | · | tweet ↗ |
| 2026-08-19 | @MrStockLockPro1 | +0.40 | Watchlist recap reports completed percentage moves for four stocks. | · | tweet ↗ |
| 2026-08-19 | @TrendSpider | +0.30 | AI scan identifies public companies advancing mRNA technology after a cancer-vaccine breakthrough. | · | tweet ↗ |
| 2026-08-19 | @Analytica_X | +0.30 | Reports positive Phase 3 cancer-vaccine results and bullish readthroughs for personalized vaccine platforms | · | tweet ↗ |
| 2026-08-19 | @Pharmdca | +0.25 | Highlights ARCT's 27% short float alongside MRNA, implying squeeze sensitivity. | · | tweet ↗ |
| 2026-08-19 | @MrStockLockPro1 | +0.45 | Morning watchlist gives conditional breakout entries, targets and stops but not the author's entry intent. | · | tweet ↗ |
| 2026-08-19 | @Pharmdca | +0.15 | Reports successful Phase 3 melanoma endpoints for Moderna and Merck, plus biotech sympathy moves and an IVVD catalyst. | · | tweet ↗ |
| 2026-08-19 | @OTR444 | +0.20 | Publishes a multi-name momentum watchlist with catalysts and market-cap data | · | tweet ↗ |
| 2026-08-19 | @Markadiusz45 | +0.15 | Lists neglected RNA-related charts generated by ChatGPT. | · | tweet ↗ |
| 2026-08-19 | @Markadiusz45 | +0.25 | Suggests an emerging RNA-stock season and supplies a multi-name thematic basket. | · | tweet ↗ |
| 2026-08-16 | @BiopharmIQ | +0.00 | Q3 biotech clinical-catalyst watchlist names phases and timing. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.